PFBT
MIRM icon

Parkside Financial Bank & Trust’s Mirum Pharmaceuticals MIRM Stock Holding History

Parkside Financial Bank & Trust’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.39K Hold
15
– – ﹤0.01% 2236
2025
Q4 		$1.19K Hold
15
– – ﹤0.01% 2281
2025
Q3 		$1.1K Hold
15
– – ﹤0.01% 2245
2025
Q2 		$764 Hold
15
– – ﹤0.01% 2352
2025
Q1 		$676 Buy
+15
New +$707 ﹤0.01% 2230

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Parkside Financial Bank & Trust's MIRM Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its Mirum Pharmaceuticals (MIRM) position steady in Q1 2026 at 15 shares worth $1.39K. The position accounts for ﹤0.01% of the portfolio, ranked #2236.

Parkside Financial Bank & Trust first reported a position in MIRM in Q1 2025 and has held it in 5 quarters since. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • Parkside Financial Bank & Trust held 15 shares of Mirum Pharmaceuticals worth $1.39K as of Q1 2026.
  • Parkside Financial Bank & Trust left its Mirum Pharmaceuticals share count unchanged in Q1 2026.
  • Mirum Pharmaceuticals made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2236 holding.
  • Parkside Financial Bank & Trust first reported a position in Mirum Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.